Translational individualised medicine: inflammation and cancer

2025 Activity indicators

  • 1 competitive national public project: ISCIII
  • 1 competitive HR contract
  • 42 publications
  • IF: 142.30
  • Publications in D1: 7 (17%)
  • Publications in Q1: 19 (45%)
  • 1 award
  • 4 doctoral theses supervised and defended
  • Evaluators for public research agencies: 2 PI
  • Editorial committee members: 1 PI

Milestones

  1. Consolidation of the MITIC-CM consortium of the R&D activities programs in Biomedicine of the Community of Madrid (B2022/BMD-7321).
  2. Boaru DL, de León D, De Castro P, García C, Fraile O, García B, Pérez I, Alhaddadin MNM, Barrena S, López L, de la Torre B, Pekarek L, Saez MA, Ríos L, Pekarek T, de la Sacristana RFG, Hernández M, Casanova C, Castel A, García N, Buján J, Díaz R, Álvarez M, Ortega MÁ. Extracellular matrix dysregulation in aging, calcifi cation, and cancer diseases: insights into cellular senescence, inflammation, and novel therapeutic strategies. Int. J. Biol. Sci. 2025;21(15): 6808 - 6881. DOI:10.7150/ijbs.119301.
  3. Award for excellence in the direction of doctoral theses at the UAH.
  4. Fraile O, García C, Álvarez MÁ, Casanova C, Fernández D, Presa M, Lahera G, Lopez L, Díaz R, Saz JV, Álvarez M, Sáez MA, Ortega MÁ. Grasping Post-Traumatic Stress Disorder (PTSD) from the Perspective of Psychoneuroimmunoendocrinology (PNIE): Etiopathogenic Mechanisms and Relevance for the Integrative Management. Biol. Psychiatry. 2025;98(10): 733 - 745. DOI:10.1016/j.biopsych.2025.01.014.
  5. Implementation of the University Chair of Research on the Central Nervous System (ADAMED).

Bibliometrics

  ARTICLES ACCUM. IF MEAN IF ARTICLES Q1 OR Q2 % IN Q1 OR Q2 ARTICLES D1 % IN D1
2021 40 174.69 4.48 34 85 4 10
2022 49 307.13 6.27 42 86 3 6
2023 45 238.46 5.55 38 84 9 20
2024 44 187.10 4.35 41 93 6 14
2025 42 142.30 3.95 34 81 7 17
  220 1049.68 4.92 189 86 29 13

* Only original articles, editorials, guidelines and reviews

Networks and alliances

  • ISCIII
  • CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD)
  • Programa Medicina Individualizada Traslacional en Inflamación y Cáncer (MITIC-CM)